Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Abroad (travel likely)Recruiting

Conditions

Crohn's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Wei Wang, MD) · weiwang0303@gmail.com · +86-020-82514458

Study leads

Wei Wang, MD
Principal Investigator
The Sixth Affiliated Hospital, Sun Yat-sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

Crohn's Disease (CD)

Abroad (travel likely)Recruiting

Cleveland, United States

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

Crohn's Disease

Abroad (travel likely)Recruiting

Guangzhou, China

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Crohn's Disease

Abroad (travel likely)RecruitingPHASE4

Le Kremlin-Bicêtre, France · Amiens, France

A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

Crohn's Disease · Ulcerative Colitis

Abroad (travel likely)Recruiting

Chongqing, China · Nîmes, France